{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:38:37Z","timestamp":1788068317647,"version":"build-2784847793"},"reference-count":69,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2025.15131","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:49:21Z","timestamp":1749124161000},"page":"1-18","source":"Crossref","is-referenced-by-count":2,"title":["Pan\u2011cancer analysis reveals the potential role of DHCR24 in bladder cancer via interactions with HRAS to facilitate cholesterol synthesis"],"prefix":"10.3892","volume":"30","author":[{"given":"Zhibin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyin","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Cell Biology, School of Life Sciences, Liaoning University, Shenyang, Liaoning 110036, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Cell Biology and Genetics, School of Basic Medical Sciences, Shenyang Medical College, Shenyang, Liaoning 110034, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"key20250703131019_b1-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40265-022-01743-x","article-title":"Potential therapeutic agents that target ATP binding cassette A1 (ABCA1) gene expression","volume":"82","author":"Haas","year":"2022","journal-title":"Drugs"},{"key":"key20250703131019_b2-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","article-title":"The coming decade in precision oncology: Six riddles","volume":"23","author":"Wahida","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"key20250703131019_b3-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1056\/NEJMoa2309457","article-title":"First-line selpercatinib or chemotherapy and pembrolizumab in RET Fusion-positive NSCLC","volume":"389","author":"Zhou","year":"2023","journal-title":"N Engl J Med"},{"key":"key20250703131019_b4-ol-30-2-15131","first-page":"78","article-title":"Hyperlipidemia: Drugs for cardiovascular risk reduction in adults","volume":"95","author":"Last","year":"2017","journal-title":"Am Fam Physician"},{"key":"key20250703131019_b5-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1002\/mco2.218","article-title":"Metabolic reprogramming in cancer: Mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023","journal-title":"MedComm (2020)"},{"key":"key20250703131019_b6-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"682911","DOI":"10.3389\/fonc.2021.682911","article-title":"Cholesterol metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy","volume":"11","author":"Giacomini","year":"2021","journal-title":"Front Oncol"},{"key":"key20250703131019_b7-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"114654","DOI":"10.1016\/j.bcp.2021.114654","article-title":"Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs","volume":"196","author":"Patel","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"key20250703131019_b8-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.coph.2012.07.006","article-title":"Cholesterol and prostate cancer","volume":"12","author":"Pelton","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"key20250703131019_b9-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1053\/j.gastro.2020.09.009","article-title":"Reduction of squalene epoxidase by cholesterol accumulation accelerates colorectal cancer progression and metastasis","volume":"160","author":"Jun","year":"2021","journal-title":"Gastroenterology"},{"key":"key20250703131019_b10-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41467-017-00910-z","article-title":"The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells","volume":"8","author":"Baek","year":"2017","journal-title":"Nat Commun"},{"key":"key20250703131019_b11-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/0008-5472.CAN-23-2278","article-title":"SUMOylation-Driven mRNA circularization enhances translation and promotes lymphatic metastasis of bladder cancer","volume":"84","author":"Zhao","year":"2023","journal-title":"Cancer Res"},{"key":"key20250703131019_b12-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1194\/jlr.M043257","article-title":"Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis","volume":"55","author":"Luu","year":"2014","journal-title":"J Lipid Res"},{"key":"key20250703131019_b13-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00441-023-03804-3","article-title":"High fat diet induces brain injury and neuronal apoptosis via down-regulating 3-\u03b2 hydroxycholesterol 24 reductase (DHCR24)","volume":"393","author":"Lu","year":"2023","journal-title":"Cell Tissue Res"},{"key":"key20250703131019_b14-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.7150\/ijms.78349","article-title":"Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer by inhibiting DHCR24 expression and modulating the AKT-mediated pathway","volume":"19","author":"Chen","year":"2022","journal-title":"Int J Med Sci"},{"key":"key20250703131019_b15-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1038\/s41416-020-01085-z","article-title":"Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation","volume":"123","author":"Wu","year":"2020","journal-title":"Br J Cancer"},{"key":"key20250703131019_b16-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"704024","DOI":"10.3389\/fonc.2021.704024","article-title":"DPP4 regulates DHCR24-mediated cholesterol biosynthesis to promote methotrexate resistance in gestational trophoblastic neoplastic cells","volume":"11","author":"Yuan","year":"2021","journal-title":"Front Oncol"},{"key":"key20250703131019_b17-ol-30-2-15131","first-page":"9109365","article-title":"GLTP is a potential prognostic biomarker and correlates with immunotherapy efficacy in cervical cancer","volume":"2022","author":"Yan-Long","year":"2022","journal-title":"Dis Markers"},{"key":"key20250703131019_b18-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2174\/1871520621666210726142814","article-title":"Anticancer effects of cinnamaldehyde through inhibition of ErbB2\/HSF1\/LDHA pathway in 5637 cell line of bladder cancer","volume":"22","author":"Zeynab","year":"2022","journal-title":"Anticancer Agents Med Chem"},{"key":"key20250703131019_b19-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"136216","DOI":"10.1016\/j.ijbiomac.2024.136216","article-title":"Synergic effects of DL-limonene, R-limonene, and cisplatin on AKT, PI3K, and mTOR gene expression in MDA-MB-231 and 5637 cell lines","volume":"280","author":"Motie","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"key20250703131019_b20-ol-30-2-15131","first-page":"224","article-title":"Evaluation of NUF2 and GMNN expression in prostate cancer: Potential biomarkers for prostate cancer screening","volume":"10","author":"Pezeshki","year":"2021","journal-title":"Rep Biochem Mol Biol"},{"key":"key20250703131019_b21-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"key20250703131019_b22-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"e1002819","DOI":"10.1371\/journal.pcbi.1002819","article-title":"Chapter 4: Protein interactions and disease","volume":"8","author":"Gonzalez","year":"2012","journal-title":"PLoS Comput Biol"},{"key":"key20250703131019_b23-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1042\/BST20211166","article-title":"Functional diversity in the RAS subfamily of small GTPases","volume":"50","author":"Astrain","year":"2022","journal-title":"Biochem Soc Trans"},{"key":"key20250703131019_b24-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Naturev"},{"key":"key20250703131019_b25-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"key":"key20250703131019_b26-ol-30-2-15131","first-page":"442","article-title":"The PyMol molecular graphics system","volume":"30","author":"Delano","year":"2002","journal-title":"Proteins Structure Function Bioinformatics"},{"key":"key20250703131019_b27-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","article-title":"Scalable molecular dynamics with NAMD","volume":"26","author":"Phillips","year":"2005","journal-title":"J Comput Chem"},{"key":"key20250703131019_b28-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.3390\/molecules28062643","article-title":"Virtual screening of Novel 24-dehydroxysterol reductase (DHCR24) inhibitors and the biological evaluation of irbesartan in Cholesterol-lowering effect","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"key20250703131019_b29-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.7150\/ijbs.63512","article-title":"Suppression of neuronal cholesterol biosynthesis impairs brain functions through insulin-like growth factor I-Akt signaling","volume":"17","author":"Liu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"key20250703131019_b30-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00894-016-2907-2","article-title":"The mechanism of the effect of U18666a on blocking the activity of 3\u03b2-hydroxysterol \u0394-24-reductase (DHCR24): Molecular dynamics simulation study and free energy analysis","volume":"22","author":"Quan","year":"2016","journal-title":"J Mol Model"},{"key":"key20250703131019_b31-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20250703131019_b32-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"166880","DOI":"10.1016\/j.bbadis.2023.166880","article-title":"Small-molecule drugs of colorectal cancer: Current status and future directions","volume":"1870","author":"Yang","year":"2024","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"key20250703131019_b33-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","article-title":"Early detection of cancer","volume":"375","author":"Crosby","year":"2022","journal-title":"Science"},{"key":"key20250703131019_b34-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.csbj.2024.12.020","article-title":"Tumour heterogeneity and personalized treatment screening based on single-cell transcriptomics","volume":"27","author":"Zhang","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"key":"key20250703131019_b35-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"9359879","DOI":"10.1155\/2022\/9359879","article-title":"SERCA3Role of in the prognosis and immune function in Pan-cancer","volume":"2022","author":"Li","year":"2022","journal-title":"J Oncol"},{"key":"key20250703131019_b36-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10020-022-00475-8","article-title":"Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction","volume":"28","author":"Song","year":"2022","journal-title":"Mol Med"},{"key":"key20250703131019_b37-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"811338","DOI":"10.3389\/fphar.2022.811338","article-title":"New insights into PTBP3 in human cancers: Immune cell infiltration, TMB, MSI, PDCD1 and m6A markers","volume":"13","author":"Fang","year":"2022","journal-title":"Front Pharmacol"},{"key":"key20250703131019_b38-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"9326","DOI":"10.3390\/ijms23169326","article-title":"Statins in high cardiovascular risk patients: Do comorbidities and characteristics matter?","volume":"23","author":"Rossini","year":"2022","journal-title":"Int J Mol Sci"},{"key":"key20250703131019_b39-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"e16845","DOI":"10.15252\/emmm.202216845","article-title":"Inhibition of DHCR24 activates LXR\u03b1 to ameliorate hepatic steatosis and inflammation","volume":"15","author":"Zhou","year":"2023","journal-title":"EMBO Mol Med"},{"key":"key20250703131019_b40-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/annonc\/mdl080","article-title":"Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer","volume":"17","author":"Bravi","year":"2006","journal-title":"Ann Oncol"},{"key":"key20250703131019_b41-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41391-018-0087-0","article-title":"Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer","volume":"22","author":"Murtola","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"key20250703131019_b42-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1158\/0008-5472.CAN-21-0646","article-title":"Oxidized Low-density lipoprotein links hypercholesterolemia and bladder cancer aggressiveness by promoting cancer stemness","volume":"81","author":"Yang","year":"2021","journal-title":"Cancer Res"},{"key":"key20250703131019_b43-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1158\/1055-9965.688.13.5","article-title":"Epstein-Barr virus and breast cancer: State of the evidence for viral carcinogenesis","volume":"13","author":"Glaser","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20250703131019_b44-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.gastro.2014.08.036","article-title":"Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer","volume":"147","author":"Liang","year":"2014","journal-title":"Gastroenterology"},{"key":"key20250703131019_b45-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol Cancer"},{"key":"key20250703131019_b46-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"175909","DOI":"10.1016\/j.ejphar.2023.175909","article-title":"PI3K\/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation","volume":"955","author":"Rezaei","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"key20250703131019_b47-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.06.004","article-title":"Targeting the genetic alterations of the PI3K-AKT-mTOR pathway: Its potential use in the treatment of bladder cancers","volume":"145","author":"Hou\u00e9d\u00e9","year":"2015","journal-title":"Pharmacol Ther"},{"key":"key20250703131019_b48-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"key20250703131019_b49-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-023-01845-4","article-title":"Beyond the anti-PD-1\/PD-L1 era: Promising role of the BTLA\/HVEM axis as a future target for cancer immunotherapy","volume":"22","author":"Sordo-Bahamonde","year":"2023","journal-title":"Mol Cancer"},{"key":"key20250703131019_b50-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4161\/sgtp.1.1.12178","article-title":"Ras history: The saga continues","volume":"1","author":"Cox","year":"2010","journal-title":"Small GTPases"},{"key":"key20250703131019_b51-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/bs.acr.2021.07.009","article-title":"Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone","volume":"153","author":"Coley","year":"2022","journal-title":"Adv Cancer Res"},{"key":"key20250703131019_b52-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2021.07.003","article-title":"A brief history of RAS and the RAS initiative","volume":"153","author":"McCormick","year":"2022","journal-title":"Adv Cancer Res"},{"key":"key20250703131019_b53-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"35374","DOI":"10.1074\/jbc.M110.148445","article-title":"Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate\/kinase interactions","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"key20250703131019_b54-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"key20250703131019_b55-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"key20250703131019_b56-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","article-title":"The frequency of ras mutations in cancer","volume":"80","author":"Prior","year":"2020","journal-title":"Cancer Res"},{"key":"key20250703131019_b57-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm0817-1004c","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"key20250703131019_b58-ol-30-2-15131","first-page":"1","article-title":"Frequency of RAS mutations (KRAS, NRAS, HRAS) in human solid cancer","volume":"1","author":"Kodaz","year":"2017","journal-title":"EJMO"},{"key":"key20250703131019_b59-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res"},{"key":"key20250703131019_b60-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"110651","DOI":"10.1016\/j.isci.2024.110651","article-title":"Knockouts of CYP51A1, DHCR24, or SC5D from cholesterol synthesis reveal pathways modulated by sterol intermediates","volume":"27","author":"Skubic","year":"2024","journal-title":"iScience"},{"key":"key20250703131019_b61-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1529\/biophysj.104.048926","article-title":"Desmosterol may replace cholesterol in lipid membranes","volume":"88","author":"Daniel","year":"2005","journal-title":"Biophys J"},{"key":"key20250703131019_b62-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"3123","DOI":"10.1210\/en.2005-1426","article-title":"DHCR24-knockout embryonic fibroblasts are susceptible to serum withdrawal-induced apoptosis because of dysfunction of caveolae and insulin-Akt-Bad signaling","volume":"147","author":"Lu","year":"2006","journal-title":"Endocrinology"},{"key":"key20250703131019_b63-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1210\/en.2008-0024","article-title":"3beta-Hydroxysteroid-delta24 reductase is a hydrogen peroxide scavenger, protecting cells from oxidative stress-induced apoptosis","volume":"149","author":"Lu","year":"2008","journal-title":"Endocrinology"},{"key":"key20250703131019_b64-ol-30-2-15131","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.21.572851","article-title":"DHCR24-mediated sterol homeostasis during spermatogenesis is required for sperm mitochondrial sheath formation and impacts male fertility over time","author":"Relovska","year":"2024"},{"key":"key20250703131019_b65-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.neulet.2012.02.072","article-title":"Testosterone up-regulates seladin-1 expression by iAR and PI3-K\/Akt signaling pathway in C6 cells","volume":"514","author":"Hengbing","year":"2012","journal-title":"Neurosci Lett"},{"key":"key20250703131019_b66-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1477-7827-6-57","article-title":"Diets high in selenium and isoflavones decrease androgen-regulated gene expression in healthy rat dorsolateral prostate","volume":"6","author":"Legg","year":"2008","journal-title":"Reprod Biol Endocrinol"},{"key":"key20250703131019_b67-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/pros.23150","article-title":"Prenatal exposure to soy and selenium reduces prostate cancer risk factors in tramp mice more than exposure beginning at six weeks","volume":"76","author":"Nakken","year":"2016","journal-title":"Prostate"},{"key":"key20250703131019_b68-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41397-024-00346-x","article-title":"Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: A comprehensive analysis using mendelian randomization, animal models, and transcriptomics","volume":"24","author":"Wei","year":"2024","journal-title":"Pharmacogenomics J"},{"key":"key20250703131019_b69-ol-30-2-15131","doi-asserted-by":"publisher","first-page":"117710","DOI":"10.1016\/j.ejmech.2025.117710","article-title":"Discovery of artesunate (ARS) PROTACs as GPX4 protein degraders for the treatment of bladder cancer","volume":"293","author":"Yang","year":"2025","journal-title":"Eur J Med Chem"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:10:24Z","timestamp":1751537424000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2025.15131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":69,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2025.15131","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]}}}